Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: J&J, Jenavalve, Mammotmoe, Myriad, Peijia, Roche, Sanofi, Spinal Elements.
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Bako, Bicycle, Daiichi, Elaris, Fulgent, Leveragen, Mirecule, Paratek, Radius, Samsung Bioepis, Sandoz, Sanofi, Siemens, Stratadx, Valneva.
Clinical updates for biopharma and med tech, including data readouts and publications: Aspen, Arvinas, Beyond Cancer, Biovica, Freenome, Gain, Okyo, Ovid, Sobi.
New hires and promotions in the biopharma and med-tech industries, including: Amphista, Femasys, Hinge Health, Imperative Care, Infinity, Isomab, Naya, Newron, Personalis.
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aldeyra, Biocardia, Fujirebio, Gyre, H.U. Group, Humacyte, Oxos, Perfuze, Polaryx, Polypid.
Clinical updates for biopharma and med tech, including data readouts and publications: Acumen, Aro, Ascendis, Ataibeckley, Candel, Cognition, Endogenex, Eupraxia, Greenwich, Heartflow, Mdxhealth, Neurosense, Pfizer, Priavoid, Rhythm.